Peptide Therapeutics Market Insights on Emerging Scope Prophesy

The global Peptide Therapeutics Market is expected to be worth US$ 47 billion in 2025, with sales increasing at an 11% CAGR from 2022 to 2025. The peptide therapeutics market is expected to grow from an estimated value of US$ 34.4 billion in 2022 due to the numerous benefits associated with the product. Peptide medicines have been used to treat metabolic illnesses for a long time and will most likely continue to be used in the future.

The market outlook for peptide therapeutics is highly positive in the coming years, owing to the benefits associated with their consumption as well as the product's wide range of applications in pharmaceuticals and the biotechnology sector. Peptide therapeutics manufacturers have recognised the critical role that their product can play in meeting unmet medical needs. Furthermore, peptide therapeutics may be a better option than small molecule and biological therapeutics. All of these factors have contributed to an increase in research and investment in peptide drug recovery over the last ten years, which is expected to bode well for the market's future prospects.

Again, rising rates of metabolic disorders and the high prevalence of cancer drive the demand for investments in peptide therapy research and development. These diseases are the leading cause of death and disability worldwide. As a result, there is a greater demand for peptide therapeutic development. Peptide-based drug delivery for cancer cells, combined with advancements in next-generation therapeutics, will presumably supplement peptide therapeutics' market expansion. Furthermore, there is a surge in interest in therapeutic peptide research for commercial reasons. As a result, it is expected that peptide drug recovery will play an important role in the healthcare industry. 

“Heightened application of peptides in the treatment of diabetes and cancer will likely augment the sales of peptide therapeutics in the global market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • The popularity of oral peptide-based drugs will create appealing market opportunities.
  • Peptide-based therapeutics will gain traction in Cosmeceuticals.
  • Government assistance to promote market growth in North America.
  • The peptide therapeutics industry will find numerous lucrative opportunities in India.
  • The parenteral route segment will continue to gain preference in terms of administration route during the assessment period.

Competitive Landscape 

Eli Lilly and Company, AstraZeneca plc, Merck & Co., Inc., Ipsen S.A, Novo Nordisk A/S, and Teva Pharmaceutical Industries Ltd., among others are some of the major players in the peptide therapeutics market that are profiled in the full version of the report.

Major players are focusing on market expansion activities in a moderately competitive market. These companies are involved in distribution agreements, white space exploration, and joint ventures. The more established companies are focusing on collaborating with local players to expand their production capacities and strengthen their regional presence.

More Information@ https://www.futuremarketinsights.com/reports/peptide-therapeutics-market

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more